{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T12:25:00Z","timestamp":1774959900178,"version":"3.50.1"},"reference-count":63,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,31]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Alopecia areata (AA) is an autoimmune hair loss disease, considered a psychosomatic disease with comorbid symptoms of depression and anxiety. Alexithymia, defined as difficulties in recognizing and describing feelings, has been found to be a vulnerability factor for developing anxiety and depression and somatic disease. The psychological burden of AA needs to be further investigated in larger studies by using standardized instruments developed to identify alexithymia, and clinical depression and anxiety. The outcome is important when treating patients with AA as well as for decisions on treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To explore the prevalence of alexithymia and its subtypes and how they relate to depressive and anxiety symptoms in patients with AA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this cohort study 100 patients with AA were interviewed about sociodemographic data, AA disease variables, and previous and present mental health. The Beck Depression Inventory-II (BDI-II), the Beck Anxiety Inventory (BAI) and the Toronto Alexithymia Scale-20 (TAS-20) were used to identify alexithymia, depression and anxiety. Associations between alexithymia and subtype scores \u2013 difficulties identifying feelings (DIF), difficulties describing feelings (DDF) and externally oriented thinking (EOT) \u2013 were analysed in relation to depression and anxiety scores. Relations between alexithymia, depressive and anxiety scores, and AA and sociodemographic variables were examined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Prevalences of depression, anxiety and alexithymia in patients with AA were 16% (n = 16\/100), 22% (n = 22\/100) and 32% (n = 32\/100), respectively. There was a statistically significant relation between DIF and anxiety and between DIF, DDF and depression. Lower levels of education were related to alexithymia, depression and anxiety symptoms. Alexithymia was statistically significantly more frequent among those who were younger at AA onset, in the relapsing form of AA and with nonfamilial AA. Previous mental affective illness was reported in 77% (n = 77\/100) of patients with AA during the life course.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Patients with AA had a higher prevalence of depression, anxiety and alexithymia compared with normative data. Alexithymia was found among those with earlier AA onset, younger age at interview and lower educational levels. Higher EOT scores were found among those with anxiety and lower education.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/skinhd\/vzaf092","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T12:37:15Z","timestamp":1762173435000},"page":"94-102","source":"Crossref","is-referenced-by-count":0,"title":["Importance of alexithymia on anxiety and depression in alopecia areata: a cohort study"],"prefix":"10.1093","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0963-9447","authenticated-orcid":false,"given":"Johan","family":"Fhager","sequence":"first","affiliation":[{"name":"Department of Care Science, Faculty of Health and Society, Malm\u00f6 University , Malm\u00f6 ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"\u00d6rmon","sequence":"additional","affiliation":[{"name":"The V\u00e4stra G\u00f6taland Region Competence Centre on Intimate Partner Violence , Gothenburg ,","place":["Sweden"]},{"name":"Department of Health, Blekinge Institute of Technology , Karlskrona ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c5ke","family":"Svensson","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, Sk\u00e5ne University Hospital, Malm\u00f6 ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Sj\u00f6str\u00f6m","sequence":"additional","affiliation":[{"name":"Department of Care Science, Faculty of Health and Society, Malm\u00f6 University , Malm\u00f6 ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,2,4]]},"reference":[{"key":"2026033107423449500_vzaf092-B1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2017.04.1141","article-title":"Alopecia areata: disease characteristics, clinical evaluation, and new perspectives on pathogenesis","volume":"1","author":"Strazzulla","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"2026033107423449500_vzaf092-B2","first-page":"397","article-title":"Epidemiology and burden of alopecia areata: a systematic review","volume":"8","author":"Villasante Fricke","year":"2015","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"2026033107423449500_vzaf092-B3","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/exd.12209","article-title":"What causes alopecia areata?","volume":"9","author":"McElwee","year":"2013","journal-title":"Exp Dermatol"},{"key":"2026033107423449500_vzaf092-B4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/bjd.21055","article-title":"The associated burden of mental health conditions in alopecia areata: a population-based study in UK primary care","volume":"1","author":"Macbeth","year":"2022","journal-title":"Br J Dermatol"},{"key":"2026033107423449500_vzaf092-B5","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.jaad.2019.05.086","article-title":"Association between alopecia areata, anxiety, and depression: a systematic review and meta-analysis","volume":"5","author":"Okhovat","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"2026033107423449500_vzaf092-B6","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/j.1365-4632.2008.03726.x","article-title":"Alexithymia and dermatology: the state of the art","volume":"9","author":"Willemsen","year":"2008","journal-title":"Int J Dermatol"},{"key":"2026033107423449500_vzaf092-B7","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1159\/000524736","article-title":"Alexithymia and cutaneous disease morbidity: a systematic review","volume":"6","author":"Holmes","year":"2022","journal-title":"Dermatology"},{"key":"2026033107423449500_vzaf092-B8","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/bjd.20628","article-title":"The epidemiology of alopecia areata: a population-based cohort study in UK primary care","volume":"2","author":"Harries","year":"2022","journal-title":"Br J Dermatol"},{"key":"2026033107423449500_vzaf092-B9","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1111\/jdv.14959","article-title":"Sex- and age-\u00adadjusted prevalence estimates of five chronic inflammatory skin diseases in France: results of the \u201cOBJECTIFS PEAU\u201d study","volume":"11","author":"Richard","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026033107423449500_vzaf092-B10","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/jid.2013.464","article-title":"Lifetime incidence risk of alopecia areata estimated at 2.1% by Rochester Epidemiology Project, 1990\u20132009","volume":"4","author":"Mirzoyev","year":"2014","journal-title":"J Invest Dermatol"},{"key":"2026033107423449500_vzaf092-B11","first-page":"e05313","article-title":"Patient characteristics and disease burden of alopecia areata in the Danish Skin Cohort","volume":"2","author":"Andersen","year":"2022","journal-title":"BMJ Open"},{"key":"2026033107423449500_vzaf092-B12","doi-asserted-by":"crossref","first-page":"e220","DOI":"10.1002\/ski2.220","article-title":"The Hairdex quality of life instrument \u2013 a translation and psychometric validation in patients with alopecia areata","volume":"3","author":"Fhager","year":"2023","journal-title":"Skin Health Dis"},{"key":"2026033107423449500_vzaf092-B13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0022-3999(94)90005-1","article-title":"The twenty-item Toronto Alexithymia Scale \u2013 I. Item selection and cross-validation of the factor structure","volume":"1","author":"Bagby","year":"1994","journal-title":"J Psychosom Res"},{"key":"2026033107423449500_vzaf092-B14","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000286529","article-title":"The prevalence of \u2018alexithymic\u2019 characteristics in psychosomatic patients","volume":"2","author":"Sifneos","year":"1973","journal-title":"Psychother Psychosom"},{"key":"2026033107423449500_vzaf092-B15","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/j.1468-3083.2009.03255.x","article-title":"Alexithymia in patients with alopecia areata: educational background much more important than traumatic events","volume":"10","author":"Willemsen","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026033107423449500_vzaf092-B16","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1080\/00223890701629698","article-title":"The assessment of alexithymia in medical settings: implications for understanding and treating health problems","volume":"3","author":"Lumley","year":"2007","journal-title":"J Pers Assess"},{"key":"2026033107423449500_vzaf092-B17","doi-asserted-by":"crossref","DOI":"10.1017\/9781108241595","volume-title":"Alexithymia: Advances in Research, Theory, and Clinical Practice","author":"Luminet","year":"2018"},{"key":"2026033107423449500_vzaf092-B18","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0022-3999(99)00083-5","article-title":"Depression is strongly associated with alexithymia in the general population","volume":"1","author":"Honkalampi","year":"2000","journal-title":"J Psychosom Res"},{"key":"2026033107423449500_vzaf092-B19","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1159\/000104709","article-title":"Long-term alexithymic features indicate poor recovery from depression and psychopathology. A six-year follow-up","volume":"5","author":"Honkalampi","year":"2007","journal-title":"Psychother Psychosom"},{"key":"2026033107423449500_vzaf092-B20","first-page":"Article 240","article-title":"Disorders of affect regulation: alexithymia in medical and psychiatric illness","volume":"3","author":"Taylor","year":"1997","journal-title":"Clin Psychol Psychother"},{"key":"2026033107423449500_vzaf092-B21","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/BF03379564","article-title":"Alexithymia and immune dysregulation: a critical review","volume":"1","author":"Uher","year":"2010","journal-title":"Act Nerv Super (Praha)"},{"key":"2026033107423449500_vzaf092-B22","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000289113","article-title":"Decreased cytotoxic lymphocyte counts in alexithymia","volume":"2","author":"Dewaraja","year":"1997","journal-title":"Psychother Psychosom"},{"key":"2026033107423449500_vzaf092-B23","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000289136","article-title":"Alexithymia, immunity and cervical intraepithelial neoplasia: replication","volume":"4","author":"Todarello","year":"1997","journal-title":"Psychother Psychosom"},{"key":"2026033107423449500_vzaf092-B24","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.3390\/jcm10061298","article-title":"Quality of life and psychological impact in patients with atopic dermatitis","volume":"10","author":"Talamonti","year":"2021","journal-title":"J Clin Med"},{"key":"2026033107423449500_vzaf092-B25","doi-asserted-by":"crossref","first-page":"111017","DOI":"10.1016\/j.jpsychores.2022.111017","article-title":"The prevalence of alexithymia in psoriasis: a systematic review and meta-analysis","volume":"161","author":"Tang","year":"2022","journal-title":"J Psychosom Res"},{"key":"2026033107423449500_vzaf092-B26","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2133.2008.08678.x","article-title":"Identification of categories at risk for high quality of life impairment in patients with vitiligo","volume":"159","author":"Sampogna","year":"2008","journal-title":"Br J Dermatol"},{"key":"2026033107423449500_vzaf092-B27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psychres.2015.02.006","article-title":"The association between alexithymia as assessed by the 20-item Toronto Alexithymia Scale and depression: a meta-analysis","volume":"1","author":"Li","year":"2015","journal-title":"Psychiatry Res"},{"key":"2026033107423449500_vzaf092-B28","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s11126-012-9246-y","article-title":"Alexithymia and emotional intelligence in patients with panic disorder, generalized anxiety disorder and major depressive disorder","volume":"3","author":"Onur","year":"2013","journal-title":"Psychiatr Q"},{"key":"2026033107423449500_vzaf092-B29","first-page":"101","article-title":"Alopesi Areata ve Aleksitimi","volume":"2","author":"Cordan Yazici","year":"2006","journal-title":"Turk Psikiyatri Derg"},{"key":"2026033107423449500_vzaf092-B30","doi-asserted-by":"crossref","first-page":"e421","DOI":"10.4103\/0019-5154.135525","article-title":"The relationship between alopecia areata and alexithymia, anxiety and depression: a case-control study","volume":"4","author":"Sellami","year":"2014","journal-title":"Indian J Dermatol"},{"key":"2026033107423449500_vzaf092-B31","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000049631","article-title":"Hopelessness, depression and alexithymia in young Turkish soldiers suffering from alopecia areata","volume":"2","author":"Sayar","year":"2001","journal-title":"Dermatol Psychosom"},{"key":"2026033107423449500_vzaf092-B32","first-page":"344","article-title":"Psychological differences between early- and late-onset psoriasis: a study of personality traits, anxiety and depression in psoriasis","volume":"169","author":"Remr\u00f6d","year":"2013","journal-title":"J Dermatol"},{"key":"2026033107423449500_vzaf092-B33","volume-title":"AUDIT: the Alcohol use Disorders Identification Test: Guidelines for use in Primary Health Care","author":"Babor","year":"2001"},{"key":"2026033107423449500_vzaf092-B34","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.paid.2018.05.011","article-title":"The psychometric assessment of alexithymia: development and validation of the Perth Alexithymia Questionnaire","volume":"132","author":"Preece","year":"2018","journal-title":"Pers Individ Dif"},{"key":"2026033107423449500_vzaf092-B35","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression","volume":"4","author":"Beck","year":"1961","journal-title":"Arch Gen Psychiatry"},{"key":"2026033107423449500_vzaf092-B36","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-5","author":"American Psychiatric Association","year":"2013","edition":"5th edn"},{"key":"2026033107423449500_vzaf092-B37","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1037\/0022-006X.56.6.893","article-title":"An inventory for measuring clinical anxiety: psychometric properties","volume":"6","author":"Beck","year":"1988","journal-title":"J Consult Clin Psychol"},{"key":"2026033107423449500_vzaf092-B38","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev-publhealth-031912-114409","article-title":"The epidemiology of depression across cultures","volume":"34","author":"Kessler","year":"2013","journal-title":"Annu Rev Public Health"},{"key":"2026033107423449500_vzaf092-B39","author":"Institute of Health Metrics and Evaluation"},{"key":"2026033107423449500_vzaf092-B40","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00005053-197301000-00001","article-title":"Anxiety states (anxiety neurosis): a review","volume":"1","author":"Marks","year":"1973","journal-title":"J\u00a0Nerv Ment Dis"},{"key":"2026033107423449500_vzaf092-B41","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1017\/S003329171200147X","article-title":"Global prevalence of anxiety disorders: a systematic review and meta-regression","volume":"5","author":"Baxter","year":"2013","journal-title":"Psychol Med"},{"key":"2026033107423449500_vzaf092-B42","author":"GBD Results Tool"},{"key":"2026033107423449500_vzaf092-B43","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1159\/000519786","article-title":"Developing motional skills and the therapeutic alliance in clients with alexithymia: intervention guidelines","volume":"6","author":"Nunes da Silva","year":"2021","journal-title":"Psychopathology"},{"key":"2026033107423449500_vzaf092-B44","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0887-6185(87)90011-9","article-title":"The role of interpersonal problems in the development of agoraphobia with panic attacks","volume":"4","author":"Kleiner","year":"1987","journal-title":"J Anxiety Disord"},{"key":"2026033107423449500_vzaf092-B45","first-page":"1491","article-title":"Chronic life stress and treatment outcome in agoraphobia with panic attacks","volume":"10","author":"Wade","year":"1993","journal-title":"Am J Psychiatry"},{"key":"2026033107423449500_vzaf092-B46","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0010-440X(91)90045-E","article-title":"Lifetime prevalence of psychiatric disorders in patients with alopecia areata","volume":"3","author":"Col\u00f3n","year":"1991","journal-title":"Compr Psychiatry"},{"key":"2026033107423449500_vzaf092-B47","first-page":"153","volume-title":"Personality Assessment","author":"Compton","year":"2004"},{"key":"2026033107423449500_vzaf092-B48","volume-title":"Manual for the State-Trait Anxiety Inventory","author":"Spielberger","year":"1970"},{"key":"2026033107423449500_vzaf092-B49","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"6","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand"},{"key":"2026033107423449500_vzaf092-B50","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jpsychores.2011.06.008","article-title":"Latent structure of the Hospital Anxiety and Depression Scale: a 10-year systematic review","volume":"3","author":"Cosco","year":"2012","journal-title":"J Psychosom Res"},{"key":"2026033107423449500_vzaf092-B51","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jpsychores.2011.12.003","article-title":"No further research needed: abandoning the Hospital and Anxiety Depression Scale (HADS)","volume":"3","author":"Coyne","year":"2012","journal-title":"J Psychosom Res"},{"key":"2026033107423449500_vzaf092-B52","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s11136-018-2050-x","article-title":"How depressed is \u201cdepressed\u201d? A systematic review and diagnostic meta-analysis of optimal cut points for the Beck Depression Inventory revised (BDI-II)","volume":"28","author":"von Glischinski","year":"2019","journal-title":"Qual Life Res"},{"key":"2026033107423449500_vzaf092-B53","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0272-7358(88)90050-5","article-title":"Psychometric properties of the Beck Depression Inventory: 25 years of evaluation","volume":"8","author":"Beck","year":"1988","journal-title":"Clin Psychol Rev"},{"key":"2026033107423449500_vzaf092-B54","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/0005-7967(94)00082-U","article-title":"The Beck Anxiety Inventory in a non-clinical sample","volume":"33","author":"Creamer","year":"1995","journal-title":"Behav Res Ther"},{"key":"2026033107423449500_vzaf092-B55","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1590\/S0102-79722013000200010","article-title":"Validity study of the Beck Anxiety Inventory (Portuguese version) by the Rasch rating scale model","volume":"26","author":"Quint\u00e3o","year":"2013","journal-title":"Psicol Reflex Crit"},{"key":"2026033107423449500_vzaf092-B56","first-page":"e425","article-title":"Executive functioning and verbal memory are predictive of alexithymia across the lifespan","volume":"3","author":"Correro","year":"2016","journal-title":"Clin Neuropsychol"},{"key":"2026033107423449500_vzaf092-B57","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0022-3999(94)90006-X","article-title":"The twenty-item Toronto Alexithymia Scale-II. Convergent, discriminant, and concurrent validity","volume":"1","author":"Bagby","year":"1994","journal-title":"J Psychosom Res"},{"key":"2026033107423449500_vzaf092-B58","doi-asserted-by":"crossref","first-page":"e109940","DOI":"10.1016\/j.jpsychores.2020.109940","article-title":"Twenty-five years with the 20-item Toronto Alexithymia Scale","volume":"131","author":"Bagby","year":"2020","journal-title":"J Psychosom Res"},{"key":"2026033107423449500_vzaf092-B59","doi-asserted-by":"crossref","first-page":"e42429","DOI":"10.1371\/journal.pone.0042429","article-title":"Alexithymia and the processing of emotional facial expressions (EFEs): systematic review, unanswered questions and further perspectives","volume":"8","author":"Grynberg","year":"2012","journal-title":"PLOS ONE"},{"key":"2026033107423449500_vzaf092-B60","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1159\/000288664","article-title":"Alexithymia and the recognition of facial expressions of emotion","volume":"3\u20134","author":"Parker","year":"1993","journal-title":"Psychother Psychosom"},{"key":"2026033107423449500_vzaf092-B61","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000089224","article-title":"The development of the Toronto Structured Interview for Alexithymia: item selection, factor structure, reliability and concurrent validity","volume":"1","author":"Bagby","year":"2006","journal-title":"Psychother Psychosom"},{"key":"2026033107423449500_vzaf092-B62","volume-title":"Affect, Imagery, Consciousness. Volume I: the Positive Affects","author":"Tomkins","year":"1962"},{"key":"2026033107423449500_vzaf092-B63","volume-title":"Affect, Imagery, Consciousness. Volume II: the Negative Affects","author":"Tomkins","year":"1963"}],"container-title":["Skin Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/skinhd\/article-pdf\/6\/2\/94\/66752596\/vzaf092.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/skinhd\/article-pdf\/6\/2\/94\/66752596\/vzaf092.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T11:42:48Z","timestamp":1774957368000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/skinhd\/article\/6\/2\/94\/8460572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,4]]},"references-count":63,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2,4]]},"published-print":{"date-parts":[[2026,3,31]]}},"URL":"https:\/\/doi.org\/10.1093\/skinhd\/vzaf092","relation":{},"ISSN":["2690-442X"],"issn-type":[{"value":"2690-442X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2026,2,4]]}}}